Angiopoietin-2 (ANG2), associated with tumor angiogenesis (Tanaka et al. 1999, 2002), has been shown to outperform AFP in predicting overall survival (OS) in HCC (Llovet et al. 2012). Here, ANGPT2 is linked to neoplasm.